Page last updated: 2024-08-24

3-methylhistidine and deferoxamine

3-methylhistidine has been researched along with deferoxamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cardillo, T; Davis, CS; Dreicer, R; Forest, PK; Kemp, JD; See, WA; Stegink, LD	1

Trials

1 trial(s) available for 3-methylhistidine and deferoxamine

Article	Year
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer. Cancer investigation, 1997, Volume: 15, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Creatinine; Deferoxamine; Drug Resistance, Neoplasm; Humans; Hydroxyproline; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methylhistidines; Middle Aged; Pelvis; Prostatic Neoplasms	1997

Article

Year

A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.

Cancer investigation, 1997, Volume: 15, Issue:4

Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Creatinine; Deferoxamine; Drug Resistance, Neoplasm; Humans; Hydroxyproline; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methylhistidines; Middle Aged; Pelvis; Prostatic Neoplasms

1997